Application of Magnetocardiography to Screen for Inflammatory Cardiomyopathy and Monitor Treatment Response.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
21 02 2023
Historique:
pubmed: 7 2 2023
medline: 25 2 2023
entrez: 6 2 2023
Statut: ppublish

Résumé

Background Inflammatory cardiomyopathy is one of the most common causes of sudden cardiac death in young adults. Diagnosis of inflammatory cardiomyopathy remains challenging, and better monitoring tools are needed. We present magnetocardiography as a method to diagnose myocardial inflammation and monitor treatment response. Methods and Results A total of 233 patients were enrolled, with a mean age of 45 (±18) years, and 105 (45%) were women. The primary analysis included 209 adult subjects, of whom 66 (32%) were diagnosed with inflammatory cardiomyopathy, 17 (8%) were diagnosed with cardiac amyloidosis, and 35 (17%) were diagnosed with other types of nonischemic cardiomyopathy; 91 (44%) did not have cardiomyopathy. The second analysis included 13 patients with inflammatory cardiomyopathy who underwent immunosuppressive therapy after baseline magnetocardiography measurement. Finally, diagnostic accuracy of magnetocardiography was tested in 3 independent cohorts (total n=23) and 1 patient, who developed vaccine-related myocarditis. First, we identified a magnetocardiography vector to differentiate between patients with cardiomyopathy versus patients without cardiomyopathy (vector of ≥0.051; sensitivity, 0.59; specificity, 0.95; positive predictive value, 93%; and negative predictive value, 64%). All patients with inflammatory cardiomyopathy, including a patient with mRNA vaccine-related myocarditis, had a magnetocardiography vector ≥0.051. Second, we evaluated the ability of the magnetocardiography vector to reflect treatment response. We observed a decrease of the pathologic magnetocardiography vector toward normal in all 13 patients who were clinically improving under immunosuppressive therapy. Magnetocardiography detected treatment response as early as day 7, whereas echocardiographic detection of treatment response occurred after 1 month. The magnetocardiography vector decreased from 0.10 at baseline to 0.07 within 7 days (

Identifiants

pubmed: 36744683
doi: 10.1161/JAHA.122.027619
pmc: PMC10111485
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e027619

Références

J Electrocardiol. 1994 Jul;27(3):233-41
pubmed: 7930986
Circulation. 2013 Nov 12;128(20):2183-91
pubmed: 24218437
JAMA. 2019 Nov 12;322(18):1799-1805
pubmed: 31714987
Circulation. 2008 Oct 21;118(17):1722-8
pubmed: 18838566
Am Heart J. 1970 Feb;79(2):223-36
pubmed: 5410953
Lancet Neurol. 2017 Jul;16(7):564-570
pubmed: 28653648
Biomed Tech (Berl). 1989;34 Suppl:205-6
pubmed: 2819163
Intern Med. 2014;53(23):2761
pubmed: 25447669
N Engl J Med. 2000 Apr 13;342(15):1077-84
pubmed: 10760308
Circ Res. 1975 Oct;37(4):471-80
pubmed: 1182939
Circ Heart Fail. 2020 Jul;13(7):e007103
pubmed: 32586108
Ann Oncol. 2007 May;18(5):881-5
pubmed: 17301071
Ann Noninvasive Electrocardiol. 2008 Oct;13(4):391-400
pubmed: 18973497
Circulation. 2010 Sep 7;122(10):985-92
pubmed: 20733097
JACC Clin Electrophysiol. 2022 Sep;8(9):1159-1161
pubmed: 36137723
J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87
pubmed: 19389557
Ann Noninvasive Electrocardiol. 2012 Oct;17(4):291-8
pubmed: 23094875
Am Heart J. 1963 Jul;66:95-6
pubmed: 14045992
Circ Heart Fail. 2018 Feb;11(2):e004228
pubmed: 29449368
Cardiology. 2006;106(4):270-6
pubmed: 16733351
JACC Clin Electrophysiol. 2018 Feb;4(2):284-287
pubmed: 29527577
Int J Card Imaging. 1991;7(3-4):151-67
pubmed: 1820397
N Engl J Med. 2021 Sep 16;385(12):1078-1090
pubmed: 34432976
Neurol Clin Neurophysiol. 2004 Nov 30;2004:82
pubmed: 16012675
N Engl J Med. 1997 Jun 26;336(26):1860-6
pubmed: 9197214
Int J Card Imaging. 1991;7(3-4):217-23
pubmed: 1726471
Br J Anaesth. 2020 Jul;125(1):e140-e147
pubmed: 32241547
J Am Coll Cardiol. 1989 Oct;14(4):915-20
pubmed: 2794278
Br J Cancer. 2002 Apr 22;86(8):1217-22
pubmed: 11953875
J Electrocardiol. 1994 Jul;27(3):221-31
pubmed: 7930985
Eur Heart J. 1993 Sep;14 Suppl E:53-60
pubmed: 8223756
PLoS One. 2016 Aug 24;11(8):e0160999
pubmed: 27556808
Circ Heart Fail. 2017 Nov;10(11):
pubmed: 29158437
J Am Heart Assoc. 2022 Aug 2;11(15):e025224
pubmed: 35904205
Can J Cardiol. 2013 Sep;29(9):1034-41
pubmed: 23623644
Nat Rev Cardiol. 2021 Mar;18(3):169-193
pubmed: 33046850
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828

Auteurs

Debora Brala (D)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Tharusan Thevathasan (T)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Simon Grahl (S)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Steve Barrow (S)

Division of Instrumentation at Space Telescope Science Institute Baltimore MD.

Michele Violano (M)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Hendrikje Bergs (H)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Ainoosh Golpour (A)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Phillip Suwalski (P)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Wolfgang Poller (W)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Carsten Skurk (C)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Ulf Landmesser (U)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.
Berlin Institute of Health at Charité Berlin Germany.

Bettina Heidecker (B)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH